Author

C Marano 1

1 Janssen Research & Development, Llc., Spring House, United States

CLINICAL OUTCOMES IN CONTINUOUS CLINICAL RESPONDERS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS: SUB-ANALYSES FROM THE PURSUIT-SC MAINTENANCE STUDY

W Reinisch, Brian G. Feagan, C Marano, R Strauss, Jewel Johanns, H Zhang, H Weng, R Yao, Dino Tarabar, Zbigniew Hebzda

Corticosteroid Sparing Effects of Ustekinumab Therapy in Ulcerative Colitis Patients: Results From the UNIFI Program

Silvio Danese, Bruce E. Sands, Laurent Peyrin-Biroulet, C Marano, Christopher O’Brien, Hongyan Zhang, Alessandra Nunes Faria Oortwijn, David Rowbotham, Rupert W Leong, Ramesh P. Arasaradnam, Gert Van Assche, William Sandborn, Remo Panaccione

Early Improvement After Intravenous Ustekinumab Induction in Patients with Ulcerative Colitis: Results from the UNIFI Induction Trial

Bruce E. Sands, Maria T. Abreu, C Marano, Thomas Baker, Christopher D. O'Brien, Hongyan Zhang, Jewel Johanns, David Rowbotham, Rupert W Leong, Silvio Danese

Item 1 - 3 / 3
1